We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$26.2B
AUM Growth
+$914M
(+3.6%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
1,591
New
69
Increased
817
Reduced
431
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$107M |
| 2 |
EXL Service
EXLS
|
+$72M |
| 3 |
Apple
AAPL
|
+$64.3M |
| 4 |
Synopsys
SNPS
|
+$56.8M |
| 5 |
ServiceNow
NOW
|
+$54.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$74.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$53.5M |
| 3 |
Edwards Lifesciences
EW
|
+$45M |
| 4 |
Abbott
ABT
|
+$40.3M |
| 5 |
Rockwell Automation
ROK
|
+$39.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.4% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 12.04% |
| 4 | Communication Services | 9.47% |
| 5 | Industrials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
CDW
CDW
$17.4B
| $4.55M | 0.02% |
26,129
-39,760
| -60% | -$7.72M |
|
452
Structure Therapeutics
GPCR
$3.83B
| $4.47M | 0.02% |
+165,000
| New | +$5.85M |
|
453
Grab
GRAB
$14.6B
| $4.39M | 0.02% |
929,274
| – | – |
|
454
IDEX
IEX
$17.6B
| $4.35M | 0.02% |
20,800
+1,200
| +6% | +$263K |
|
|
JNPR
455
DELISTED
Juniper Networks
JNPR
| $4.35M | 0.02% |
116,200
+37,500
| +48% | +$1.42M |
|
456
Check Point Software Technologies
CHKP
$13.3B
| $4.35M | 0.02% |
23,307
+1,838
| +9% | +$346K |
|
457
Icon
ICLR
$12.8B
| $4.34M | 0.02% |
20,676
-1,033
| -5% | -$241K |
|
458
Quest Diagnostics
DGX
$26.1B
| $4.3M | 0.02% |
28,488
+542
| +2% | +$84.3K |
|
459
Manhattan Associates
MANH
$11.3B
| $4.29M | 0.02% |
15,888
+500
| +3% | +$142K |
|
460
Owens Corning
OC
$12.4B
| $4.28M | 0.02% |
25,100
+3,000
| +14% | +$561K |
|
461
Amdocs
DOX
$6.1B
| $4.27M | 0.02% |
50,115
+2,910
| +6% | +$255K |
|
462
Twilio
TWLO
$38.6B
| $4.23M | 0.02% |
39,100
-1,700
| -4% | -$155K |
|
463
XPO
XPO
$24.9B
| $4.22M | 0.02% |
32,200
+1,900
| +6% | +$257K |
|
464
Nucor
NUE
$62B
| $4.21M | 0.02% |
36,096
-10,108
| -22% | -$1.45M |
|
465
RPM International
RPM
$14.4B
| $4.2M | 0.02% |
34,132
+2,500
| +8% | +$330K |
|
466
Molina Healthcare
MOH
$10.8B
| $4.17M | 0.02% |
14,337
-100
| -0.7% | -$30.9K |
|
467
Global E Online
GLBE
$6.99B
| $4.14M | 0.02% |
75,870
+5,312
| +8% | +$240K |
|
468
Builders FirstSource
BLDR
$7.95B
| $4.13M | 0.02% |
28,919
-800
| -3% | -$142K |
|
469
Pentair
PNR
$10.5B
| $4.12M | 0.02% |
40,900
| – | – |
|
470
Sun Communities
SUI
$14.6B
| $4.07M | 0.02% |
33,116
| – | – |
|
471
Avery Dennison
AVY
$13.5B
| $4.06M | 0.02% |
21,700
-900
| -4% | -$184K |
|
472
KeyCorp
KEY
$24.6B
| $4.05M | 0.02% |
236,553
+88,657
| +60% | +$1.59M |
|
473
Entegris
ENTG
$25.3B
| $4.04M | 0.02% |
40,826
-400
| -1% | -$42.2K |
|
474
Amcor
AMCR
$21.5B
| $4.01M | 0.02% |
85,300
-3,442
| -4% | -$180K |
|
475
FTAI Aviation
FTAI
$22.5B
| $3.98M | 0.02% |
27,600
+600
| +2% | +$88.5K |
|
Similar funds
VIA
Handelsbanken Fonder's Q4 2024 Portfolio in Review
As of Q4 2024, Handelsbanken Fonder held 1,591 positions worth $26.2B, up 3.6% from $25.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder deployed $1.01B of net new capital in Q4 2024, opening 69 new positions and adding to 817 existing holdings. Its largest new stake was GE Vernova: 105,537 shares worth $34.7M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Halozyme, an estimated $74.5M trimmed.
- Handelsbanken Fonder's largest Q4 2024 buy was GE Vernova: 105,537 shares worth $34.7M.
- Handelsbanken Fonder added most to Microsoft in Q4 2024, an estimated $107M increase.
- Handelsbanken Fonder's biggest Q4 2024 reduction was Halozyme, cutting an estimated $74.5M.
- Handelsbanken Fonder fully exited BeOne Medicines Ltd in Q4 2024, selling an estimated $5.92M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $26.2B portfolio in Q4 2024.
- Handelsbanken Fonder opened 69 new positions and closed 49 in Q4 2024.
- Handelsbanken Fonder's portfolio value rose 3.6% quarter-over-quarter to $26.2B.
Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.